Clean Bite, LLC is preparing for a General Solicitation under

SEC “Regulation D,” Rule 506c, for Accredited Investors Only

The information on this site is for Press Release purposes only, and no public offering

or PPA is being made or solicited at this time for the sale of equity or any other purpose

If there is interest on the part of a potential investor, they may ask to be placed on a “notify me list” by emailing [email protected] and typing “notify me list” in the subject line. Clean Bite, LLC will try to notify anyone who has made this request.

N.B. Be advised there is no guarantee that we will be able to accommodate that request or that the transmission of such a request can be verified. Therefore, we recommend that you check back frequently.

Clean Bite, LLC’s stock in trade is its Intellectual Property comprised of Patents, awarded in the United States of America, and recent Allowed in the European Union and India as of September 20, 2023. The protection these Patents represent is significant while being strengthened through the collaboration with Livionex, Inc., makers of LivFresh Dental Gel and their global Patents. The Clean Bite™ products are unmatched in design and purpose, and LivFresh has been proven through testing to be superior to its competition in removing plaque and preventing and treating gingivitis and periodontitis.

LivFresh’s being awarded the CE Mark caused Clean Bite to contemplate following suit

Clean Bite, LLC is preparing for a General Solicitation under SEC “Regulation D,” Rule 506c, for Accredited Investors Only The information on this site is for Press Release purposes only, and no public offering or PPA is being made or solicited at this time for the sale of equity or any other purpose.

If there is interest on the part of a potential investor, they may ask to be placed on a “notify me list” by emailing [email protected] and typing “notify me list” in the subject line. Clean Bite, LLC will try to notify anyone who has made this request.

N.B. Be advised there is no guarantee that we will be able to accommodate that request or that the transmission of such a request can be verified. Therefore, we recommend that you check back frequently.

Clean Bite, LLC’s Global Outlook

Fourth Quarter 2023

Press Release –

Clean Bite, LLC’s stock in trade is its Intellectual Property comprised of Patents, awarded in the United States of America, and recent Allowed in the European Union and India as of September 20, 2023. The protection these Patents represent is significant while being strengthened through the collaboration with Livionex, Inc., makers of LivFresh Dental Gel and their global Patents. The Clean Bite™ products are unmatched in design and purpose, and LivFresh has been proven through testing to be superior to its competition in removing plaque and preventing and treating gingivitis and periodontitis.

LivFresh being awarded the CE Mark in the EU caused Clean Bite to following suit in filing for patent protection in the EU and India.  LivFresh is designated by its CE Mark as the only OTC (over the counter) dentifrice to prevent and treat gingivitis and periodontitis. The prevalence of gingivitis in adults over 30 years of age in the U.S. is on the order of 65M, and it is the precursor to the more serious periodontitis that can lead to the loss of teeth and bone structure.

These conditions are not exclusive to people, as dogs and cats at three years of age have a preponderance of gingivitis on the magnitude of 70% and 80%, respectively. Clean Bite™ products are for people and companion pets. Adding LivFresh to the equation has the significance of being a force multiplier that goes beyond just brushing teeth and clean breath. RESEARCHANDMARKETS.COM’s recent publication on the Pet Oral Care Products Market Forecast from 2021 to 2028 sights a CAGR of 6.5%, $1,465.07M in 2021 to $2,270.33M in 2028.

Another aspect is using the Clean Bite™ products as a delivery system for vitamins, therapeutics, medications, and vaccines. Therefore, getting involved in the API market application would better be done by a pharmaceutical company, using a licensing or another type of Agreement. We believe that one beneficial API application is in addressing parasitic diseases that plague the developing world.

The future of Clean Bite, LLC and Livionex, Inc. as a collaborative effort offers seemingly boundless opportunities. The short-term goal is to develop high-speed manufacturing equipment and its deployment first in the United States while establishing alliances in the EU and India. The first most likely foreign operational base will be in Ireland, as the EU Headquarters.

Attempting to isolate the market into segments quickly becomes academic when R&D is the most relevant milestone to be accomplished. For example, targeting specific markets as low-hanging fruit, identifying supply chains for raw material, and distribution networks are all things that can be milestones during the equipment development period.

The question on the minds of investors will likely be, how big is this opportunity? In the United States, we believe the largest single market is at-risk children who receive meals at school and have horrible dental statistics. For about 38₵ per Clean Bite™I, these children can brush their teeth following every meal, and because the collagen inherently contains 5 to 6 grams of protein per brush, it could be a net-zero trade-off for another item on the tray with less protein.

Using that price point scenario, per school year of 180 days would be $68.40. If one cavity is prevented per student, the savings could be significant considering the range of costs for a filling being $50 to $300 or more depending on the number of faces involved on the tooth.

The USDA will sponsor all student meals for the 2021-2022 school year but was not continue. The number of meals is around 10 billion per year, not including other programs through the summer outside of the school year. Those multiples work out to $3.42 Billion; it also pales in comparison to the aggregate market of the United States.

Compared to the populations just in the countries where we have defensible Intellectual Property, it represents more than 25% of the world’s population, not including those countries where the CE Mark holds greater recognition than the approval of the FDA.

John H. Gallagher, Jr.

Managing Director

Clean Bite, LLC

[email protected]

Clean Bite, LLC Business Plan is under Revision, available 4th Q 2023.